Andreas Charalambous, Chair Department of Nursing at Cyprus University of Technology and MASCC Executive Board Member, shared a post on LinkedIn about a paper he co-authored with colleagues published in ESMO Open:
“Publication Alert.
‘From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development’.
This manuscript introduces a robust and adaptive framework for fast-track safety evaluation, tailored to the specific needs of oncology drug development. The proposed framework is designed to provide a systematic approach for assessing patient safety throughout the drug development process, ensuring that critical safety concerns are addressed in a timely and effective manner.
By integrating flexible evaluation mechanisms, the framework aims to maintain rigorous safety standards while also facilitating the efficient progression of drugs through accelerated regulatory pathways. This dual focus on safety and speed is intended to balance the need for rigorous safety oversight with the urgency of providing promising new therapies to patients in need, thereby enhancing both clinical trial outcomes and overall patient well-being.”
Title: From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development
Authors: S. Champiat, K. Ouali, A. Laparra, A. Charalambous, M. Di Palma, K. Jordan, C. Massard, M. Aapro, F. Scotte
You can read the Full Article in ESMO Open.
More posts featuring Andreas Charalambous.